Related Experiment Video
Updated: Mar 26, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Expression and functional role of miR-29b in renal cell carcinoma
Yi Xu1, Jianyong Zhu1, Zhangming Lei1
1Department of Urology, Quzhou People's Hospital Quzhou 324000, Zhejiang, China.
Objectives:
microRNAs (miRNAs) play essential roles in many tumors, including renal cell carcinoma (RCC). The aim of the present study was to investigate the expression and functional role of miR-29b in RCC and to identify its target genes.
Methods:
We determined the expression of miR-29b in clear cell RCC (ccRCC) tissues and RCC cell lines (786-O, A498, and SN12-PM6) using quantitative real-time PCR (qRT-PCR). The associations between miR-29b expression and clinical pathological parameters and prognosis were explored. Besides, the role of miR-29b in the SN12-PM6 cells proliferation, apoptosis, cycle, and invasion were investigated after transduction with lentivirus vectors. The kines in family member 1B (KIF1B), possible miR-29b target genes, were predicted using bioinformatics approaches, as well as the role in the pathogenesis of RCC.
Results:
Elevated expression of miR-29b was found in both tumor tissues and cell lines. High expression of miR-29b was significantly associated with tumor-node-metastasis (TNM) stage (P = 0.026) and the overall survival (P = 0.009) in the ccRCC. Inhibition of miR-29b expression could promote apoptosis, and inhibit proliferation and invasion ability in SN12-PM6 cells. Also, we confirmed that miR-29b could directly regulate the expression of KIF1B at the post transcriptional level.
Conclusion:
These data suggest that miR-29b acts as an oncomiR, promoting proliferation and invasion ability through KIF1B suppression, and it might be a potential marker for prognosis of RCC.
Insights
MicroRNA-29b (miR-29b) is elevated in renal cell carcinoma (RCC), promoting tumor growth and invasion by suppressing KIF1B. This suggests miR-29b may serve as a prognostic marker for RCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial regulators in various cancers, including renal cell carcinoma (RCC).
- Understanding the specific roles of miRNAs like miR-29b in RCC pathogenesis is essential for developing targeted therapies.
- The expression and function of miR-29b in RCC remain incompletely elucidated.
Purpose of the Study:
- To investigate the expression profile of miR-29b in renal cell carcinoma (RCC).
- To explore the functional significance of miR-29b in RCC cell proliferation, apoptosis, cell cycle, and invasion.
- To identify and validate target genes of miR-29b involved in RCC pathogenesis.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) was used to determine miR-29b expression in ccRCC tissues and cell lines.
- Lentivirus vectors were employed to manipulate miR-29b levels in SN12-PM6 cells to assess functional impacts.
- Bioinformatics approaches were utilized to predict and investigate Kinesin Family Member 1B (KIF1B) as a potential miR-29b target.
Main Results:
- miR-29b expression was significantly upregulated in both ccRCC tumor tissues and cell lines.
- High miR-29b expression correlated with advanced Tumor-Node-Metastasis (TNM) stage and poorer overall survival in ccRCC patients.
- Inhibition of miR-29b suppressed proliferation and invasion while promoting apoptosis in RCC cells, and directly downregulated KIF1B expression.
Conclusions:
- miR-29b functions as an oncomiR in RCC, driving proliferation and invasion via suppression of its target gene, KIF1B.
- miR-29b may serve as a valuable prognostic biomarker for renal cell carcinoma.
- Targeting miR-29b could represent a potential therapeutic strategy for RCC.
Related Concept Videos
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

